U.S. health authorities Saturday agreed to permit emergency use of a 2nd antibody drug to help the immune system fight COVID-19, an experimental medication that President Donald Trump was offered when he was sickened last month.
The Food and Drug Administration licensed usage of the Regeneron Pharmaceuticals Inc. drug to attempt to prevent hospitalization and intensifying illness from developing in clients with mild-to-moderate symptoms.
The drug is offered as a one-time treatment through an IV. The FDA enabled its usage in grownups and children 12 and over who weigh at least 88 pounds (40 kgs) and who are at high danger of serious health problem from COVID-19 due to the fact that of age or specific other medical conditions.
Emergency permission allows use of the drug to begin while research studies are continuing to establish safety and efficiency. Early outcomes suggest t